Last reviewed · How we verify

NCT06821074

Defocus-Enhanced vs. Single Vision Spectacles in Myopia Control Visual Function Training

Recruiting now NA Last updated 24 April 2025
What this trial tests

NA trial testing Defocus-enhanced spectacles in Myopia in 1,000 participants. Currently enrolling.

Timeline
8 February 2025
Primary endpoint
31 December 2026
28 February 2027

Quick facts

Lead sponsorBeijing Visionly Plus Eye Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment1,000
Start date8 February 2025
Primary completion31 December 2026
Estimated completion28 February 2027
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Visionly Plus Eye Hospital

Who can join

Adults 6 to 18, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the effectiveness of vision function training using defocus-enhanced spectacles (DIMS) versus single vision spectacles combined with vision function training in controlling myopia progression in children aged 6-18 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Beijing Visionly Plus Eye Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06821074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing